RecruitingAutosomal Dominant Polycystic KidneyRenal CystAutosomal Dominant Polycystic Liver Disease
A Prospective Observational Study of Foam Sclerotherapy .
Eligible age
18–100 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/liver cyst volumes at up to 12 months of follow-up in patients with autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD).
Sponsor: Mayo Clinic
You may qualify if…
- ✓ Age ≥18 years
- ✓ Clinical diagnosis of ADPKD or ADPLD
- ✓ 1-3 large, non-exophytic liver or kidney cyst
- ✓ Compressive symptoms from dominant cyst
You may not qualify if…
- ✕ Age \<18 years
- ✕ Absence of ADPKD or ADPLD
- ✕ Largest cyst \<4cm in all 3 dimensions or largest cyst volume \<400cc
- ✕ \>3 large, non-exophytic liver or kidney cyst(s) ≥4cm in all 3 dimensions (cyst volume ≥400cc)
- ✕ Unwilling to comply with study follow-up protocol to 12 ± 1months post-FS
- ✕ Lacking capacity to provide informed consent to FS of liver or kidney cysts
- ✕ Pregnancy
Where it's recruiting
Minnesota
Rochester
Source: ClinicalTrials.gov · NCT04111692 · last updated 2026-01-26